Early intervention with intranasal NPY prevents single prolonged stress-triggered impairments in hypothalamus and ventral hippocampus in male rats

Endocrinology (United States)

Volumn 155, Issue 10, 2014, Pages 3920-3933

  Laukova, Marcela ^a   Alaluf, Lishay G ^a   Serova, Lidia I ^a   Arango, Victoria ^b   Sabban, Esther L ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID RECEPTOR; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DENTATE GYRUS; EARLY INTERVENTION; GENETIC TRANSCRIPTION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MEDIOBASAL HYPOTHALAMUS; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SINGLE PROLONGED STRESS; STRESS; ANIMAL; COMPLICATION; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMIC DISEASES; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRANASAL DRUG ADMINISTRATION; MENTAL STRESS; PATHOPHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT; STRESS DISORDERS, POST-TRAUMATIC;

ADMINISTRATION, INTRANASAL; ANIMALS; HIPPOCAMPUS; HYPOTHALAMIC DISEASES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; MALE; NEUROPEPTIDE Y; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL;

EID: 84907190275     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1192     Document Type: Article

References (121)

1. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry. 2001;62(suppl 17):41-46.
2. Pervanidou P, Chrousos GP. Neuroendocrinology of post-traumatic stress disorder. Prog Brain Res. 2010;182:149-160.
3. Yehuda R. Neuroendocrine aspects of PTSD. Handb Exp Pharmacol. 2005(169):371-403.
4. Pitman RK, Rasmusson AM, Koenen KC, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012;13(11): 769-787.
5. Bremner JD, Licinio J, Darnell A, et al. Elevated CSF corticotropinreleasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry. 1997;154(5):624-629.
6. Baker DG, West SA, Nicholson WE, et al. Serial CSF corticotropinreleasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1999; 156(4):585-588.
7. de Kloet CS, Vermetten E, Geuze E, et al. Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder. Prog Brain Res. 2008;167:287-291.
8. Kjelstrup KG, Tuvnes FA, Steffenach HA, Murison R, Moser EI, Moser MB. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci USA. 2002;99(16):10825-10830.
9. Radley JJ, Sawchenko PE. A common substrate for prefrontal and hippocampal inhibition of the neuroendocrine stress response. J Neurosci. 2011;31(26):9683-9695.
10. Herman JP, Dolgas CM, Carlson SL. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive stressors. Neuroscience. 1998;86(2):449-459.
11. Herman JP. Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system. Cell Mol Neurobiol. 1993;13(4):349-372.
12. Reul JM, de Kloet ER. Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. J Steroid Biochem. 1986;24(1): 269-272.
13. Eagle AL, Knox D, Roberts MM, et al. Single prolonged stress enhances hippocampal glucocorticoid receptor and phosphorylated protein kinase B levels. Neurosci Res. 2013;75(2):130-137.
14. Liberzon I, López JF, Flagel SB, Vázquez DM, Young EA. Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback: relevance to post-traumatic stress disorder. J Neuroendocrinol. 1999;11(1):11-17.
15. Kohda K, Harada K, Kato K, et al. Glucocorticoid receptor activation is involved in producing abnormal phenotypes of singleprolonged stress rats: a putative post-traumatic stress disorder model. Neuroscience. 2007;148(1):22-33.
16. Serova LI, Tillinger A, Alaluf LG, Laukova M, Keegan K, Sabban EL. Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats. Neuroscience. 2013;236:298-312.
17. Kozlovsky N, Matar MA, Kaplan Z, Zohar J, Cohen H. A distinct pattern of intracellular glucocorticoid-related responses is associated with extreme behavioral response to stress in an animal model of post-traumatic stress disorder. Eur Neuropsychopharmacol. 2009;19(11):759-771.
18. Bremner JD. Hypotheses and controversies related to effects of stress on the hippocampus: an argument for stress-induced damage to the hippocampus in patients with posttraumatic stress disorder. Hippocampus. 2001;11(2):75-81; discussion 82-74.
19. Wang Z, Xiao ZP. Magnetic resonance imaging study of hippocampus structural alterations in post-traumatic stress disorder: a brief review (translated version). East Asian Arch Psychiatry. 2010;20(3):138-144.
20. Knox D, Nault T, Henderson C, Liberzon I. Glucocorticoid receptors and extinction retention deficits in the single prolonged stress model. Neuroscience. 2012;223:163-173.
21. Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol. 2013;132(5):1033-1044.
22. Schmidt U, Kaltwasser SF, Wotjak CT. Biomarkers in posttraumatic stress disorder: overview and implications for future research. Dis Markers. 2013;35(1):43-54.
23. Wochnik GM, Rüegg J, Abel GA, Schmidt U, Holsboer F, Rein T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem. 2005;280(6):4609-4616.
24. Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology. 2000;141(11): 4107-4113.
25. Grad I, Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol. 2007;275(1-2):2-12.
26. Cohen H, Liu T, Kozlovsky N, Kaplan Z, Zohar J, Mathé AA. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology. 2012;37(2):350-363.
27. Gutman AR, Yang Y, Ressler KJ, Davis M. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci. 2008;28(48):12682-12690.
28. Karlsson RM, Holmes A, Heilig M, Crawley JN. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav. 2005;80(3):427-436.
29. Sah R, Geracioti TD. Neuropeptide Y and posttraumatic stress disorder. Mol Psychiatry. 2013;18(6):646-655.
30. Serova LI, Laukova M, Alaluf LG, Sabban EL. Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress. Behav Brain Res. 2013;250: 139-147.
31. Vahl TP, Ulrich-Lai YM, OstranderMM,et al. Comparative analysis of ACTH and corticosterone sampling methods in rats. Am J Physiol Endocrinol Metab. 2005;289(5):E823-E828.
32. Noguchi T, Makino S, Matsumoto R, et al. Regulation of glucocorticoid receptor transcription and nuclear translocation during single and repeated immobilization stress. Endocrinology. 2010; 151(9):4344-4355.
33. Spiga F, Lightman SL. Dose-dependent effects of corticosterone on nuclear glucocorticoid receptors and their binding to DNA in the brain and pituitary of the rat. Brain Res. 2009;1293:101-107.
34. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. New York, NY: Academic Press, Inc; 1998.
35. Bali B, Ferenczi S, Kovács KJ. Direct inhibitory effect of glucocorticoids on corticotrophin-releasing hormone gene expression in neurones of the paraventricular nucleus in rat hypothalamic organotypic cultures. J Neuroendocrinol. 2008;20(9):1045-1051.
36. Jeanneteau FD, Lambert WM, Ismaili N, et al. BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc Natl Acad Sci USA. 2012; 109(4):1305-1310.
37. Wang Z, Frederick J, Garabedian MJ. Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. J Biol Chem. 2002;277(29):26573-26580.
38. Myers B, McKlveen JM, Herman JP. Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress. Front Neuroendocrinol. 2014;35(2):180-196.
39. Givalois L, Arancibia S, Tapia-Arancibia L. Concomitant changes in CRH mRNA levels in rat hippocampus and hypothalamus following immobilization stress. Brain Res Mol Brain Res. 2000; 75(1):166-171.
40. Ivy AS, Rex CS, Chen Y, et al. Hippocampal dysfunction and cognitive impairments provoked by chronic early-life stress involve excessive activation of CRH receptors. J Neurosci. 2010;30(39): 13005-13015.
41. Daskalakis NP, Yehuda R, Diamond DM. Animal models in translational studies of PTSD. Psychoneuroendocrinology. 2013;38(9): 1895-1911.
42. Daskalakis NP, Lehrner A, Yehuda R. Endocrine aspects of posttraumatic stress disorder and implications for diagnosis and treatment. Endocrinol Metab Clin North Am. 2013;42(3):503-513.
43. Steudte S, Kolassa IT, Stalder T, Pfeiffer A, Kirschbaum C, Elbert T. Increased cortisol concentrations in hair of severely traumatized Ugandan individuals with PTSD. Psychoneuroendocrinology. 2011;36(8):1193-1200.
44. Elzinga BM, Schmahl CG, Vermetten E, van Dyck R, Bremner JD. Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology. 2003;28(9): 1656-1665.
45. Baker DG, Ekhator NN, Kasckow JW, et al. Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 2005;162(5):992-994.
46. Maes M, Lin A, Bonaccorso S, et al. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand. 1998;98(4):328-335.
47. Fukuda S, Morimoto K, Mure K, Maruyama S. Effect of the Hanshin-Awaji earthquake on posttraumatic stress, lifestyle changes, and cortisol levels of victims. Arch Environ Health. 2000;55(2): 121-125.
48. Pervanidou P, Chrousos GP. Posttraumatic stress disorder in children and adolescents: neuroendocrine perspectives. Sci Signal. 2012;5(245):pt6.
49. Handwerger K. Differential patterns ofHPAactivity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv Rev Psychiatry. 2009;17(3):184-205.
50. Delahanty DL, Raimonde AJ, Spoonster E. Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol Psychiatry. 2000;48(9):940-947.
51. Resnick HS, Yehuda R, Pitman RK, Foy DW. Effect of previous trauma on acute plasma cortisol level following rape. Am J Psychiatry. 1995;152(11):1675-1677.
52. Johnson DM, Delahanty DL, Pinna K. The cortisol awakening response as a function of PTSD severity and abuse chronicity in sheltered battered women. J Anxiety Disord. 2008;22(5):793-800.
53. Anisman H, Griffiths J, Matheson K, Ravindran AV, Merali Z. Posttraumatic stress symptoms and salivary cortisol levels. Am J Psychiatry. 2001;158(9):1509-1511.
54. Ma XM, Camacho C, Aguilera G. Regulation of corticotropinreleasing hormone (CRH) transcription and CRH mRNA stability by glucocorticoids. Cell Mol Neurobiol. 2001;21(5):465-475.
55. Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci. 2013;34(9):518-530.
56. Vreugdenhil E, Verissimo CS, Mariman R, et al.MicroRNA18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology. 2009; 150(5):2220-2228.
57. Turner JD, Alt SR, Cao L, et al. Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more. Biochem Pharmacol. 2010;80(12):1860-1868.
58. Uchida S, Nishida A, Hara K, et al. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur J Neurosci. 2008;27(9):2250-2261.
59. Chrousos GP, Kino T. Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann NY Acad Sci. 2009;1179:153-166.
60. Galliher-Beckley AJ, Cidlowski JA. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormoneaction in health and disease.IUBMBLife. 2009;61(10):979-986.
61. Boscarino JA, Erlich PM, Hoffman SN, Zhang X. Higher FKBP5, COMT,CHRNA5,andCRHR1allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment. Neuropsychiatr Dis Treat. 2012;8:131-139.
62. Boscarino JA, Erlich PM, Hoffman SN, Rukstalis M, Stewart WF. Association of FKBP5,COMTandCHRNA5polymorphisms with PTSD among outpatients at risk for PTSD. Psychiatry Res. 2011; 188(1):173-174.
63. Laryea G, Schütz G, Muglia LJ. Disrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adiposity. Mol Endocrinol. 2013;27(10):1655-1665.
64. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 2000;886(1-2):172-189.
65. Wang HT, Han F, Shi YX. Activity of the 5-HT1A receptor is involved in the alteration of glucocorticoid receptor in hippocampus and corticotropin-releasing factor in hypothalamus in SPS rats. Int J Mol Med. 2009;24(2):227-231.
66. Fanselow MS, Dong HW. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron. 2010;65(1):7-19.
67. Maggio N, Segal M. Steroid modulation of hippocampal plasticity: switching between cognitive and emotional memories. Front Cell Neurosci. 2012;6:12.
68. Scharf SH, Liebl C, Binder EB, Schmidt MV, Müller MB. Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS One. 2011;6(2):e16883.
69. Datson NA, van der Perk J, de Kloet ER, Vreugdenhil E. Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur J Neurosci. 2001;14(4):675-689.
70. Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev. 1991;12(2):118-134.
71. Herman JP, Figueiredo H, Mueller NK, et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 2003;24(3):151-180.
72. Chaouloff F, Hémar A, Manzoni O. Acute stress facilitates hippocampal CA1 metabotropic glutamate receptor-dependent longterm depression. J Neurosci. 2007;27(27):7130-7135.
73. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997;20(2):78-84.
74. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10(6):397-409.
75. Li XM, Han F, Liu DJ, Shi YX. Single-prolonged stress induced mitochondrial-dependent apoptosis in hippocampus in the rat model of post-traumatic stress disorder. J Chem Neuroanat. 2010; 40(3):248-255.
76. Li X, Han F, Liu D, Shi Y. Changes of Bax, Bcl-2 and apoptosis in hippocampus in the rat model of post-traumatic stress disorder. Neurol Res. 2010;32(6):579-586.
77. Liu H, Han F, Shi Y. Effect of calreticulin on Ca2/CaM kinaseII and endoplasmic reticulum stress in hippocampal in a rat model of post-traumatic stress disorder. Neurochem Res. 2013;38(7):1407-1414.
78. McEwen BS. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism. 2005;54(5 suppl 1):20-23.
79. MagariñosAM,McEwenBS. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience. 1995;69(1):89-98.
80. McEwen BS, Magarinos AM. Stress effects on morphology and function of the hippocampus. Ann NY Acad Sci. 1997;821:271-284.
81. Chetty S, Friedman AR, Taravosh-Lahn K, et al. Stress and glucocorticoids promote oligodendrogenesis in the adult hippocampus [published online February 11, 2014]. Mol Psychiatry. doi: 10.1038/mp.2013.190
82. Maras PM, Molet J, Chen Y, et al. Preferential loss of dorsalhippocampus synapses underlies memory impairments provoked by short, multimodal stress. Mol Psychiatry. 2014;19(7):811-822.
83. Uys JD, Marais L, Faure J, et al. Developmental trauma is associated with behavioral hyperarousal, altered HPA axis activity, and decreased hippocampal neurotrophin expression in the adult rat. Ann NY Acad Sci. 2006;1071:542-546.
84. Herman JP, Cullinan WE, Morano MI, Akil H, Watson SJ. Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis. J Neuroendocrinol. 1995;7(6):475-482.
85. Maras PM, Baram TZ. Sculpting the hippocampus from within: stress, spines, and CRH. Trends Neurosci. 2012;35(5):315-324.
86. Regev L, Baram TZ. Corticotropin releasing factor in neuroplasticity. Front Neuroendocrinol. 2014;35(2):171-179.
87. Chen Y, Andres AL, Frotscher M, Baram TZ. Tuning synaptic transmission in the hippocampus by stress: the CRH system. Front Cell Neurosci. 2012;6:13.
88. Yan XX, Toth Z, Schultz L, Ribak CE, Baram TZ. Corticotropinreleasing hormone (CRH)-containing neurons in the immature rat hippocampal formation: light and electron microscopic features and colocalization with glutamate decarboxylase and parvalbumin. Hippocampus. 1998;8(3):231-243.
89. Kovács KJ. CRH: the link between hormonal-, metabolic-and behavioral responses to stress. J Chem Neuroanat. 2013;54:25-33.
90. Meijer OC, Steenbergen PJ, De Kloet ER. Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology. 2000;141(6): 2192-2199.
91. Chen Y, Kramár EA, Chen LY, et al. Impairment of synaptic plasticity by the stress mediator CRH involves selective destruction of thin dendritic spines via RhoA signaling. Mol Psychiatry. 2013; 18(4):485-496.
92. Chen Y, Bender RA, Brunson KL, et al. Modulation of dendritic differentiation by corticotropin-releasing factor in the developing hippocampus. Proc Natl Acad Sci USA. 2004;101(44):15782-15787.
93. Chen Y, Rex CS, Rice CJ, et al. Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing hormone signaling. Proc Natl Acad Sci USA. 2010;107(29):13123-13128.
94. Dhuria SV, Hanson LR, FreyWH.Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99(4):1654-1673.
95. Chapman CD, FreyWH2nd, Craft S, et al. Intranasal treatment of central nervous system dysfunction in humans. Pharm Res. 2013; 30(10):2475-2484.
96. Thorne RG, Emory CR, AL TA, Frey WH. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res. 1995;692(1-2):278-282.
97. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004;127(2):481-496.
98. Ionescu IA, Dine J, Yen YC, et al. Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons. Neuropsychopharmacology. 2012;37(6):1323-1337.
99. Rat D, Schmitt U, Tippmann F, et al. Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor proteintransgenic mice. FASEB J. 2011;25(9):3208-3218.
100. Nonaka N, Farr SA, Nakamachi T, et al. Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins. Peptides. 2012;36(2):168-175.
101. Eaton K, Sallee FR, Sah R. Relevance of neuropeptide Y (NPY) in psychiatry. Curr Top Med Chem. 2007;7(17):1645-1659.
102. Wu G, Feder A, Wegener G, et al. Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets. 2011;15(11):1317-1331.
103. Kask A, Harro J, von Hörsten S, Redrobe JP, Dumont Y, Quirion R. The neurocircuitry and receptor subtypes mediating anxiolyticlike effects of neuropeptide Y. Neurosci Biobehav Rev. 2002; 26(3):259-283.
104. Dimitrov EL, DeJoseph MR, Brownfield MS, Urban JH. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity. Endocrinology. 2007;148(8):3666-3673.
105. Wahlestedt C, Skagerberg G, Ekman R, Heilig M, Sundler F, Hakanson R. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res. 1987;417(1):33-38.
106. Suda T, Tozawa F, Iwai I, et al. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Brain Res Mol Brain Res. 1993;18(4):311-315.
107. Pronchuk N, Beck-Sickinger AG, Colmers WF. Multiple NPY receptors Inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. Endocrinology. 2002;143(2):535-543.
108. Horvath TL, Bechmann I, Naftolin F, Kalra SP, Leranth C. Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res. 1997;756(1-2):283-286.
109. Füzesi T, Wittmann G, Liposits Z, Lechan RM, Fekete C. Contribution of noradrenergic and adrenergic cell groups of the brainstem and agouti-related protein-synthesizing neurons of the arcuate nucleus to neuropeptide-y innervation of corticotropin-releasing hormone neurons in hypothalamic paraventricular nucleus of the rat. Endocrinology. 2007;148(11):5442-5450.
110. Blasquez C, Jégou S, Friard O, Tonon MC, Fournier A, Vaudry H. Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat. Neuroscience. 1995;68(1):221-227.
111. Liposits Z, Sievers L, Paull WK. Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic levels. Histochemistry. 1988;88(3-6):227-234.
112. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides. 2004;38(4):213-224.
113. Palkovits M. Stress-induced activation of neurons in the ventromedial arcuate nucleus: a blood-brain-CSF interface of the hypothalamus. Ann NY Acad Sci. 2008;1148:57-63.
114. Heilig M, Koob GF, Ekman R, Britton KT. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 1994;17(2):80-85.
115. Thorsell A. Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Exp Biol Med (Maywood). 2010;235(10):1163-1167.
116. Sajdyk TJ, Shekhar A, Gehlert DR. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides. 2004;38(4):225-234.
117. Kash TL, WinderDG.NeuropeptideYand corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology. 2006;51(5):1013-1022.
118. Nostramo R, Tillinger A, Serova L, Kvetnansky R, Sabban EL. Bradykinin B2 receptor in the adrenal medulla of male rats and mice: glucocorticoid-dependent increase with immobilization stress. Endocrinology. 2013;154(10):3729-3738.
119. Liu Y, He M, Sun X, Peng K, Zhao L. Alteration of nuclear protein profiling for NIH-3T3 cells exposed toH2O2. Cell Biochem Funct. 2010;28(7):578-584.
120. MathenyRWJr, Nindl BC. Loss of IGF-IEa or IGF-IEb impairs myogenic differentiation. Endocrinology. 2011;152(5):1923-1934.
121. Stanić D, Kuteeva E, Nylander I, Hökfelt T. Characterization of CGRP protein expression in "satellite-like" cells and dendritic arbours of the mouse olfactory bulb. J Comp Neurol. 2010; 518(6): 770-784.